Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 veliparib + carboplatin/paclitaxel in Japanese subjects with solid tumors
jRCT2080221796Phase 1
- Sponsor
- AbbVie Inc.
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of veliparib in Non-hematologic malignancy, sponsored by AbbVie Inc.
02
Drugs
veliparib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080221796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221796.